-
A 52-year-old woman with no significant past medical history presented to Stanford Hospital in July, 2014, with fever and progressive weakness. She had been in her usual state of health until the day prior to admission, when she began to feel fatigued with subjective fevers and “restless legs.”
-
Dalbavancin is a lipoglycopeptide antibiotic for intravenous administration with activity against Gram-positive organisms, including methicillin resistant Staphylococcus aureus that is distinguished by its extraordinarily long serum half-life that allows once weekly dosing.
-
From 2001 to 2013, Bailey and colleagues studied 65,480 children in a primary care network affiliated with Children’s Hospital of Pennsylvania that covered urban and suburban parts of Pennsylvania, New Jersey, and Delaware.
-
Declining rates of response to standard treatment for non-gonococcal urethritis (NGU) may prompt changes in accepted treatment strategies.
-
The fda has approved the first naloxone hand-held auto-injector. It is intended for family members or caregivers to treat suspected opioid overdose. The auto-injector can be carried in a pocket or stored in a medicine cabinet. The product was reviewed under the agencys priority review program. It is marketed by Kaleo, Inc. as Evzio.
-
Bendopnea, which is defined as shortness of breath when bending over, has been found to be a dominant symptom in patients with heart failure. It appears to be caused by a further increase in filling pressures when bending over in patients with heart failure, especially when filling pressures are already high and the cardiac index is reduced.
-
In a study of veterans with no recent history of depression or opioid use, the risk of developing depression increased as the duration of opioid analgesic exposure increased.
-
The authors concluded that vitamin D supplementation in patients with fibromyalgia syndrome (FMS) and low levels of vitamin D might be an economical, safe, and effective therapy for patients with FMS.
-
-
